Peroxisome proliferator-activated receptor gamma and cancers
about
sameAs
The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic CancerThe role of peroxisome proliferator-activated receptors in carcinogenesis and chemopreventionReactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growthAdvances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapyRole of nuclear receptors in breast cancer stem cellsAdipocytes: impact on tumor growth and potential sites for therapeutic interventionChemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancerPPARδ activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesisPPARγ as a Novel Therapeutic Target in Lung CancerCommonalities in the Association between PPARG and Vitamin D Related with Obesity and CarcinogenesisSynergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A ReviewCEACAM1 modulates epidermal growth factor receptor--mediated cell proliferationHic-5 regulates an epithelial program mediated by PPARgammaA compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative abilityCytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaPeroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancerCOX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situRosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.Regulatory subunits of PKA define an axis of cellular proliferation/differentiation in ovarian cancer cellsDifferentiation therapy of leukemia: 3 decades of development.Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4In vivo effects of rosiglitazone in a human neuroblastoma xenograft.Energy restriction as an antitumor target of thiazolidinediones.PPARγ in head and neck cancer preventionThiazolidinediones are partial agonists for the glucocorticoid receptor.Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levelsA pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemiaPTB-associated splicing factor (PSF) is a PPARγ-binding protein and growth regulator of colon cancer cells.Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer.MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.Role of traditional and new biomarkers in breast carcinogenesis.The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma.PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
P2860
Q21342813-65B60B61-47E4-4F96-909F-2FE42E3EAD1CQ24601222-FCC3E6C8-FB4F-46FB-AAAE-8D89FCD1A8A9Q24651313-BD05FD70-88D1-48D7-8314-C34F37E5ABDAQ24803990-B8CAAEE2-7835-4494-B096-CBABEA2D1821Q26750359-3BF4A305-7F1E-4264-82EB-136351C518BCQ26830077-DD33F68F-477F-4F59-9629-DDA8705A9CD8Q27026428-524C9436-5B79-4169-BA08-586B7813CB32Q27437643-068CA3EA-85F1-4570-90A8-9D1B5B1D0EB9Q28068114-CFCD595B-9CE2-4E13-BE35-03A9D6186C55Q28070220-3ADA91FA-BD08-4994-A714-3DE342460877Q28074119-9689C714-CC06-449D-9446-BA87DD0D5E6EQ28116188-C4521CF8-4457-43BC-8B65-B2E94B810D2EQ28586821-549AD546-A4B4-43B7-97D1-B136EC88C206Q28818450-4907518E-9C87-4A1F-B164-DE56794E7AECQ31093216-453033EC-6832-4782-9C91-F53EB34B71CCQ33235601-FC7F23D4-67F7-43E7-8220-5DEE3BDCB588Q33251021-54AC69EB-3343-46A3-962C-B32EC210586CQ33317621-C3C8518B-E391-4DFC-B77B-5E8377934A8AQ33318963-F4E324AA-9581-4BEC-B5F4-C7768DC6D77CQ33372446-7A2DFD3A-F59A-4E3B-8F00-C6CFE9D8EE24Q33409795-76EFA2B0-BD14-4DE6-86CD-BF33CBCBCB3DQ33532809-11106CE2-AAC7-4A06-A605-101FADBDAE01Q33701419-542A8E2F-6379-4C3B-9717-B462751F6E0EQ33723620-54153AAE-CADD-415B-BEB9-77828BF77651Q33744668-B38B4A6A-EE5A-4BD6-90FF-4B435DA6E368Q33896090-E81DDD9F-896F-4382-BB33-DE0EF471FB64Q33948063-C2AF9535-39A1-4024-B14E-82D2EC5F8BF6Q34099115-AADE1ED3-F13E-4ABA-A7D8-8B118838603CQ34315365-C1C41DE0-B7B8-4BAA-8CBD-E41DB40E371BQ34448969-1E376ABB-0935-4261-972E-2DA28C086A41Q34629987-1ED75EC7-42AC-433B-99C5-C13F30666214Q34646050-1EEE45D6-76C9-4515-ADEA-88C806B7F328Q34685429-DD9FCCBD-E8F8-485F-B819-9E540C134F62Q35188070-3C3A709D-80CD-47F4-B285-7EB24EB650A1Q35249254-5E7B44BD-7BB6-4919-AA7E-01378FC61237Q35458969-598D527A-FBCD-4793-A843-556F3C4F275BQ35572905-47E5FD1C-6D6B-4E71-B6DB-B1CD43070579Q35599140-EBF12ABC-0660-4574-92E3-ADF4D00DED6CQ35770556-A57868E8-204B-4EC7-855D-1B9CE2D06F52Q35927161-E1361183-B616-41B7-B75E-C15D1D65A1E3
P2860
Peroxisome proliferator-activated receptor gamma and cancers
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Peroxisome proliferator-activated receptor gamma and cancers
@ast
Peroxisome proliferator-activated receptor gamma and cancers
@en
Peroxisome proliferator-activated receptor gamma and cancers
@nl
type
label
Peroxisome proliferator-activated receptor gamma and cancers
@ast
Peroxisome proliferator-activated receptor gamma and cancers
@en
Peroxisome proliferator-activated receptor gamma and cancers
@nl
prefLabel
Peroxisome proliferator-activated receptor gamma and cancers
@ast
Peroxisome proliferator-activated receptor gamma and cancers
@en
Peroxisome proliferator-activated receptor gamma and cancers
@nl
P3181
P1476
Peroxisome proliferator-activated receptor gamma and cancers
@en
P2093
H Phillip Koeffler
P3181
P407
P577
2003-01-01T00:00:00Z